Guardian Pharmacy Q1 revenue $336.6M (+2% YoY); raises FY Adjusted EBITDA guidance to $123-127M

Guardian Pharmacy Services, Inc.

Revenue $336.6M (+2% YoY); residents served 207K (+10% YoY). Net income $13.5M vs $9.3M.
Adjusted EBITDA $29.8M vs $23.4M; diluted EPS $0.21, adjusted EPS $0.29.
FY 2026 guidance: revenue unchanged $1.40-1.42B; Adjusted EBITDA raised to $123-127M from $120-124M.
Cash $64.9M, no debt on credit facility; completed non-dilutive secondary offering of 6.9M shares in March 2026.
Company offset IRA pricing resets, maintaining margin stability.

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 1.0

Guardian Pharmacy Services, Inc. reported the quarter ended March 31, 2026 results: revenue $336.6 million, net income $13.5 million, EPS $0.21. Guidance raised.

Period: the quarter ended March 31, 2026
Revenue: $336.6 million
Net income: $13.5 million
EPS: $0.21
Guidance: raised
Result: reported results

Exact text from the filing

announced today its financial results for the first quarter ended March 31, 2026. The Company also updated its full-year guidance. First Quarter Financial Results • Revenue of $336.6 million, up 2% year-over-year. • Residents served ended the quarter at approximately 207,000, up 10% year-over-year. • Net Income of $13.5 million, compared to $9.3 million in the

View on SEC.gov

Browse all earnings releases →

Guardian Pharmacy Services, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-26-208989

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.